Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Li-ESWT with or without tadalafil for diabetic vasculogenic erectile dysfunction
IRCT20260727070376N1Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in erectile dysfunction (ED) and Vascular Erectile Dysfunction comparing Li-ESWT + tadalafil with Li-ESWT + placebo (2 arms). Primary endpoint: Change in International Index of Erectile Function-Erectile Function domain score. Started Aug 2026; status: recruiting.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)Vascular Erectile Dysfunction
Beyond the preview
Go deeper on IRCT20260727070376N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260727070376N1.